Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | ALPL | P05186 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585314 | 0.87 | CA1 (0.56) | CA1CA2CA9TSHR | |
| SCHEMBL4345099 | 0.83 | CA1 (0.46) | CA1CA2CA9TSHR | |
| SCHEMBL9957855 | 0.81 | CA1 (0.44) | CA1CA2CA9TSHRHSD17B10 | |
| SCHEMBL28988340 | 0.79 | CA1 (0.48) | CA1CA2CA9 | |
| SCHEMBL9957399 | 0.77 | CA1 (0.46) | CA1CA2CA9TSHRHSD17B10 | |
| SCHEMBL13488483 | 0.76 | CA1 (0.40) | CA1CA2CA9 | |
| SCHEMBL17356397 | 0.76 | SMN1; SMN2 (0.43) | CA1CA2CA9TSHRKMT2A | |
| SCHEMBL3742731 | 0.74 | CA1 (0.41) | CA1CA2CA9CYP1A2ALPL | |
| SCHEMBL9958126 | 0.74 | CA1 (0.43) | CA1CA2CA9TSHR | |
| SCHEMBL29210219 | 0.74 | CA1 (0.31) | CA1CA2CA9KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | CA1 1448/4885CA2 286/4885CA9 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.